Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Landmark Cancer Center is a private U.S. oncology care provider and cancer treatment center rather than a drug-development biotech or pharmaceutical company. Publicly available information indicates the organization has operated in Rogers, Arkansas under the Landmark Cancer Center name, offering radiation oncology and related cancer care services, with references to chemotherapy, immunotherapy, imaging, and supportive care. Corporate records also show Landmark Cancer Center, LLC in Arkansas, while directory and media sources suggest the Rogers center was at one point rebranded as GenesisCare. Because the name has also appeared as a trade name associated with Highlands Oncology Group in Arkansas, the exact current operating structure is somewhat ambiguous. For biotech-style fields such as molecular targets and R&D pipeline, there is no clear evidence of a proprietary therapeutic pipeline; Landmark appears best characterized as a commercial oncology services organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Landmark Cancer Center.